REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 136 filers reported holding REVANCE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.72 and the average weighting 0.5%.
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $371 | +64.9% | 15,200 | 0.0% | 0.05% | +35.3% |
| Q1 2020 | $225 | -87.8% | 15,200 | -86.6% | 0.03% | -71.9% |
| Q4 2019 | $1,842 | +165.4% | 113,544 | +112.6% | 0.12% | +44.0% |
| Q3 2019 | $694 | +1.6% | 53,400 | +1.4% | 0.08% | -1.2% |
| Q2 2019 | $683 | -23.5% | 52,672 | -7.1% | 0.08% | -30.3% |
| Q1 2019 | $893 | -21.7% | 56,672 | 0.0% | 0.12% | -23.3% |
| Q4 2018 | $1,141 | -21.7% | 56,672 | -3.4% | 0.16% | -23.2% |
| Q3 2018 | $1,458 | +60.4% | 58,672 | +77.3% | 0.21% | +71.1% |
| Q2 2018 | $909 | +224.6% | 33,100 | +263.7% | 0.12% | +236.1% |
| Q1 2018 | $280 | -13.8% | 9,100 | 0.0% | 0.04% | -33.3% |
| Q4 2017 | $325 | – | 9,100 | – | 0.05% | – |
Download | ||||||